company background image
7733

Olympus TSE:7733 Stock Report

Last Price

JP¥2.69k

Market Cap

JP¥3.4t

7D

0.2%

1Y

24.8%

Updated

02 Jul, 2022

Data

Company Financials +
7733 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance6/6
Financial Health5/6
Dividends0/6

7733 Stock Overview

Olympus Corporation manufactures and sells precision machineries and instruments worldwide.

Olympus Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Olympus
Historical stock prices
Current Share PriceJP¥2,686.50
52 Week HighJP¥2,834.50
52 Week LowJP¥1,998.00
Beta0.89
1 Month Change-0.26%
3 Month Change15.77%
1 Year Change24.78%
3 Year Change122.03%
5 Year Change163.38%
Change since IPO701.94%

Recent News & Updates

Shareholder Returns

7733JP Medical EquipmentJP Market
7D0.2%-1.1%-1.1%
1Y24.8%-14.6%-7.0%

Return vs Industry: 7733 exceeded the JP Medical Equipment industry which returned -14.6% over the past year.

Return vs Market: 7733 exceeded the JP Market which returned -7% over the past year.

Price Volatility

Is 7733's price volatile compared to industry and market?
7733 volatility
7733 Average Weekly Movement5.6%
Medical Equipment Industry Average Movement4.6%
Market Average Movement4.2%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.2%

Stable Share Price: 7733 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 7733's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191931,557Yasuo Takeuchihttps://www.olympus-global.com

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services.

Olympus Fundamentals Summary

How do Olympus's earnings and revenue compare to its market cap?
7733 fundamental statistics
Market CapJP¥3.42t
Earnings (TTM)JP¥115.74b
Revenue (TTM)JP¥868.87b

29.5x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
7733 income statement (TTM)
RevenueJP¥868.87b
Cost of RevenueJP¥297.17b
Gross ProfitJP¥571.70b
Other ExpensesJP¥455.95b
EarningsJP¥115.74b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 09, 2022

Earnings per share (EPS)90.92
Gross Margin65.80%
Net Profit Margin13.32%
Debt/Equity Ratio75.5%

How did 7733 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

16%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 7733 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7733?

Other financial metrics that can be useful for relative valuation.

7733 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4x
Enterprise Value/EBITDA15x
PEG Ratio2.6x

Price to Earnings Ratio vs Peers

How does 7733's PE Ratio compare to its peers?

7733 PE Ratio vs Peers
The above table shows the PE ratio for 7733 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average26x
4543 Terumo
34.2x11.6%JP¥3.0t
6869 Sysmex
38.8x12.0%JP¥1.7t
6951 JEOL
21.2x15.7%JP¥260.2b
6849 Nihon Kohden
10x-4.3%JP¥233.2b
7733 Olympus
29.5x11.4%JP¥3.4t

Price-To-Earnings vs Peers: 7733 is expensive based on its Price-To-Earnings Ratio (29.5x) compared to the peer average (26x).


Price to Earnings Ratio vs Industry

How does 7733's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

Price-To-Earnings vs Industry: 7733 is expensive based on its Price-To-Earnings Ratio (29.5x) compared to the JP Medical Equipment industry average (14.4x)


Price to Earnings Ratio vs Fair Ratio

What is 7733's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7733 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.5x
Fair PE Ratio33x

Price-To-Earnings vs Fair Ratio: 7733 is good value based on its Price-To-Earnings Ratio (29.5x) compared to the estimated Fair Price-To-Earnings Ratio (33x).


Share Price vs Fair Value

What is the Fair Price of 7733 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7733 (¥2686.5) is trading below our estimate of fair value (¥3309.35)

Significantly Below Fair Value: 7733 is trading below fair value, but not by a significant amount.


Price to Earnings Growth Ratio

PEG Ratio: 7733 is poor value based on its PEG Ratio (2.6x)


Discover undervalued companies

Future Growth

How is Olympus forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


11.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7733's forecast earnings growth (11.4% per year) is above the savings rate (0.04%).

Earnings vs Market: 7733's earnings (11.4% per year) are forecast to grow faster than the JP market (8.9% per year).

High Growth Earnings: 7733's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7733's revenue (6.7% per year) is forecast to grow faster than the JP market (4.5% per year).

High Growth Revenue: 7733's revenue (6.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7733's Return on Equity is forecast to be high in 3 years time (22%)


Discover growth companies

Past Performance

How has Olympus performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


9.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 7733 has high quality earnings.

Growing Profit Margin: 7733's current net profit margins (13.3%) are higher than last year (9%).


Past Earnings Growth Analysis

Earnings Trend: 7733's earnings have grown by 9.4% per year over the past 5 years.

Accelerating Growth: 7733's earnings growth over the past year (76.4%) exceeds its 5-year average (9.4% per year).

Earnings vs Industry: 7733 earnings growth over the past year (76.4%) exceeded the Medical Equipment industry 14.9%.


Return on Equity

High ROE: 7733's Return on Equity (22.7%) is considered high.


Discover strong past performing companies

Financial Health

How is Olympus's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 7733's short term assets (¥694.6B) exceed its short term liabilities (¥376.3B).

Long Term Liabilities: 7733's short term assets (¥694.6B) exceed its long term liabilities (¥470.4B).


Debt to Equity History and Analysis

Debt Level: 7733's net debt to equity ratio (14.3%) is considered satisfactory.

Reducing Debt: 7733's debt to equity ratio has increased from 66.5% to 75.5% over the past 5 years.

Debt Coverage: 7733's debt is well covered by operating cash flow (44%).

Interest Coverage: 7733's interest payments on its debt are well covered by EBIT (45.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Olympus's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.60%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 7733's dividend (0.6%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.69%).

High Dividend: 7733's dividend (0.6%) is low compared to the top 25% of dividend payers in the JP market (3.74%).


Stability and Growth of Payments

Stable Dividend: 7733 is not paying a notable dividend for the JP market, therefore no need to check if payments are stable.

Growing Dividend: 7733 is not paying a notable dividend for the JP market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: 7733 is not paying a notable dividend for the JP market.


Cash Payout to Shareholders

Cash Flow Coverage: 7733 is not paying a notable dividend for the JP market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Yasuo Takeuchi (65 yo)

3.25yrs

Tenure

JP¥131,000,000

Compensation

Mr. Yasuo Takeuchi has been Chief Executive Officer and President of Olympus Corporation since April 1, 2019 and has been its Representative Executive Officer since 2019. He served as Chief Financial Offic...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Yasuo's total compensation is reasonable compared to companies of similar size in the JP market.

Compensation vs Earnings: Insufficient data to compare Yasuo's compensation with company performance.


Leadership Team

Experienced Management: 7733's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: 7733's board of directors are considered experienced (3.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Olympus Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Olympus Corporation
  • Ticker: 7733
  • Exchange: TSE
  • Founded: 1919
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: JP¥3.420t
  • Shares outstanding: 1.27b
  • Website: https://www.olympus-global.com

Number of Employees


Location

  • Olympus Corporation
  • Shinjuku Monolith
  • 3-1 Nishi-Shinjuku 2-chome
  • Tokyo
  • 163-0914
  • Japan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/02 00:00
End of Day Share Price2022/07/01 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.